In R/R Follicular Lymphoma, Tisa-Cel Produces Long-Lasting Responses.

Published Date: 29 Dec 2023

Our panel of experts talks about the phase II ELARA study's three-year results.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

How to keep your prostate healthy and lower your risk of developing serious problems

2.

Treatment of Smoldering Myeloma Cuts Progression Rate in Half

3.

PSA Testing Is Not Enough for Another Candidate for Prostate Cancer Screening.

4.

AI is useful in low-resource areas for triaging breast masses.

5.

Can Prior Authorization Be Better With Artificial Intelligence?


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot